American drugmaker Johnson & Johnson is facing an investigation for high tuberculosis medication prices. The Competition Commission will investigate J&J for the price it has been charging for the tuberculosis medicine bedaquiline.
Health advocates have questioned why SA is paying about twice as much as other low- and middle-income countries. South Africa has one of the highest TB disease rates in the world.
Doctors Without Borders Access Campaign Advocacy officer, Candice Sehoma, elaborates on this.
For more news, visit sabcnews.com and #SABCNews on all Social Media platforms.
